In The News

August 7, 2017

Veritas Genetics Scoops Up an AI Company to Sort Out Its DNA

By Nick Stockton, WIRED

Genes carry the information that make you you. So it's fitting that, when sequenced and stored in a computer, your genome takes up gobs of memory—up to 150 gigabytes. Multiply that across all the people who have gotten sequenced, and you're looking at some serious storage issues. If that's not enough, mining those genomes for useful insight means comparing them all to each other, to medical histories, and to the millions of scientific papers about genetics.


August 3, 2017

Veritas Buys Curoverse to Bring A.I. Analysis of Genes to the Masses

By Frank Vinluan, Xconomy

Some answers to questions about the risk of developing a disease or a bad reaction to a drug can be found by analyzing a patient’s genes. In the not-too-distant future, such queries could be as easy as searching for and selecting a movie on Netflix, contends Rodrigo Martinez, chief marketing and design officer for Veritas Genetics.


June 27, 2017

50 Smartest Companies 2017

By MIT Technology Review Editors, MIT Technology Review

Each year we identify 50 companies creating new opportunities by combining important technologies and business savvy. Some are large companies that seem to be growing ever larger, like Amazon and Apple. Others, like IBM, or General Electric are old-guard giants betting on technology renewal...


June 26, 2017

Routine DNA Sequencing May Be Helpful And Not As Scary As Feared

By Rob Stein, NPR’s All Things Considered

Advances in technology have made it much easier, faster and less expensive to do whole genome sequencing — to spell out all three billion letters in a person's genetic code. Falling costs have given rise to speculation that it could soon become a routine part of medical care, perhaps as routine as checking your blood pressure.


April 11, 2017

Veritas Genetics and WCH Join Forces to Provide BRCA Testing to All

By Frances Addison, Front Line Genomics

Veritas Genetics have announced that they’re collaborating with Dr. Steven Narod, co-discoverer of the BRCA1 and BRCA2 genes, from Women’s College Hospital (WCH) in Toronto to provide adult Canadians unprecedented access to BRCA testing. Dr. Narod will be working alongside the Director of the Research Molecular Genetics Laboratory at WCH, Dr. Mohammad Akbari, as co-principal investigator. Veritas will be supporting the project by performing the genetic tests involved.


April 6, 2017

FDA Opens Genetic Floodgates with 23andMe Decision

By Emily Mullin, MIT Technology Review

Today, the U.S. Food and Drug Administration told gene-testing company 23andMe that it will be allowed to directly tell consumers whether their DNA puts them at higher risk for 10 different diseases, including late-onset Alzheimer’s disease and Parkinson’s.


March 23, 2017

The Genetic Secrets of the World’s Greatest Free Diver (2nd of a 3-part series)

By Amanda Schaffer,  Medium and NeoLife

In the mid-1990s, an academically gifted Bosnian teenager named Mirza Cifric sent a plea to thousands of people through an online bulletin board system. The Bosnian War had come to an end, but Cifric, already a serial entrepreneur since middle school, saw little future in his homeland and wanted to pursue a college education elsewhere. Strangers from around the world responded to him, and eventually, through an organization devoted to helping Bosnian children, he was matched with a family living outside of Boston. Cifric says he printed the invitation on his Star LC20 dot matrix printer and ran to his mother, waving the paper and shouting, “Mom, Mom, I’m going to America!” Cifric’s mother, who worked in the Bosnian court system and liked to see documents stamped and certified, was skeptical about the arrangement. Nonetheless, she put her son on a plane to Boston with around 500 German marks ($200) sewn into his pants.


March 16, 2017

With Key Hire, Cambridge-Based Veritas Genetics Takes Leap Toward Affordable Genome Sequencing

By Renee Morad, BioSpace

Last year, Danvers, Mass.-based Veritas Genetics unveiled a genetic test that provides six billion letters of a person’s genome, access to a smartphone app that highlight the most significant takeaways and a summary of medical dispositions— from inherited cancers to neurological disorders — and on-demand video calls with a genetic counselor, for just $999. That’s a big step toward affordability.


March 14, 2017

Decoding the Diver (1st of a 3-part series)

By Amanda Schaffer, Medium and NeoLife

In July 2016, William Trubridge, a champion free diver from New Zealand, floated on his back above Dean’s Blue Hole in the Bahamas, ready to submerge. For weeks, he had prepared for this record attempt, training in and out of the water, and taking evening walks along the nearby limestone cliffs to “clear the lactic acid from my muscles and cobwebs from my mind.”


March 8, 2017

Gormley’s Take: Startups Play It Safe on Genetic Data for Consumers

By Brian Gormley, WSJ Pro Venture Capital

A new crop of startups is bringing genomics information to consumers- and learning from the regulatory bumps and bruises suffered by pioneer 23andMe Inc.


February 8, 2017

Startup Spotlight: Seeking to Improve the $999 Genome for Consumers

By Kate Sheridan, STAT+

Just under a year ago, Veritas Genetics announced it would be launching the first whole genome sequencing test with a price tag under $1,000. Now, the company is bringing on board a new vice president of clinical affairs to help lower the cost of that sequencing and improve the process of interpreting the results.


January 21, 2017

The genomics intelligence revolution

By Mahni Ghorashi, Gaurav Garg, techcrunch / crunch network

We’ve entered a new phase in the history of whole genome sequencing (WGS). Consider that researchers at University of Toronto just launched a massive project to sequence the whole genomes of 10,000 people per year. This is truly astounding when you recall that it took 13 years and $3 billion to sequence the first human genome, and that as recently as 2012 there were only 69 whole human genomes that had ever been sequenced.


October 17, 2016

Veritas Genetics draws $30 million in funding

By Robert Weisman, Boston Globe

Veritas Genetics, a two-year-old startup that offers whole genome sequencing to consumers for under $1,000, said Monday it raised $30 million from a trio of investors.

The Danvers-based company was founded by Harvard Medical School genetics professor George Church, and last year gathered $12 million from Lilly Asia Ventures, a Shanghai-based affiliate of US drug maker Eli Lilly & Co. that is a leading biomedical investor. Asian investors also figured heavily in the new funding round, led by Trustbridge Partners, a private equity firm with offices in Boston and Shanghai. Trustbridge was joined by Lilly Asia and Jiangsu Simcere Pharmaceutical of Nanjing, one of China’s largest drug companies.


August 4, 2016

Racing toward personalized medicine

By Tom Keenan, Calgary Herald

Admit it. Back in 2013 when you heard that Angelina Jolie had undergone a preventive double mastectomy because of high genetic risk of breast cancer, you probably thought, “I’m glad I’m a guy.” Men do get breast cancer, but it’s much less common than in women. Well, gentlemen, now it’s our turn, though maybe not for such extreme measures. New findings published in the July 6 issue of The New England Journal of Medicine cast the spotlight on the same BRCA1 and BRCA2 genes that drove Jolie’s decision, as well as others with names like ATM, CHEK2 and RAD51D.


June 29, 2016

The mystery of the spaceman…

By Liz Harley, Front Line Genomics

Festival goers were surprised to see a mysterious and oddly silent spaceman patrolling the exhibition. The enigmatic astronaut caused quite the stir at Race the Helix, winning best dressed runner despite only managing a few feet of distance, and all the out of this world antics on the Festival floor were captured for posterity by Veritas Genetics.


June 21, 2016

50 Smartest Companies 2016

By MIT Technology Review Editors, MIT Technology Review

Each year we identify 50 companies that are “smart” in the way they create new opportunities. Some of this year’s stars are large companies, like Amazon and Alphabet, that are using digital technologies to redefine industries. Others are wrestling with technological changes: companies like Microsoft, Bosch, Toyota, and Int.


April 21, 2016

The rapidly changing landscape of genetic testing for consumers and providers

By Healthiscool, Health Standards – Expanding Conversation on Healthcare Technology

Consumers have a growing number of choices for genetic testing. But with more choice comes more confusion. There is growing pressure on providers to order tests and provide access to genetic counseling. However, genetic counselors are struggling to keep up with the demand, and consumers can find themselves faced with unanticipated and sometimes lengthy wait times.


April 7, 2016

Veritas launch $999 genome

By Liz Harley, Front Line Genomics

Cheaper genomics is here, and it comes with an app. This month Boston-based startup Veritas Genetics began taking orders for its myGenome service, a $999 genome sequence that delivers interpretation direct to users’ smartphones.


April 6, 2016

Is Knowing Your Full Genome a Right or a Privilege?

By Lauren Vogelbaum, HowStuffWorks NOW

Your genome is written in your very cells, but is having access to it a privilege? Until recently, genome sequencing was too expensive to be considered accessible to the average human – and even though prices are dropping, it’s still not cheap.


April 1, 2016

Whole-genome breakthrough promises tonic for healthcare

By Clive Cookson, Financial Times

Commentators have long looked forward to the “thousand-dollar human genome” — the ability to sequence accurately all 3bn letters of an individual’s DNA for less than $1,000. In 2016 it seems likely to happen, 15 years after the completion of the first whole human genome in a decade-long $3bn research programme.


March 28, 2016

How Veritas Genetics Plans to Make Its $999 Whole Genome Stick

By Aaron Krol, Bio-IT World

This month, Veritas Genetics, a DNA testing company based in Cambridge, Mass., began taking orders for its $999 myGenome service. Customers will mail saliva samples to the Veritas lab, where their DNA will be extracted and their entire genomes sequenced.


March 9, 2016

You can now sequence your entire genome for under $1,000

By Peter Dockrill, WHN Forum for Anti-Aging and Regenerative Medicine

It wasn't all that long ago that the first human genome was sequenced – a massive, globally orchestrated scientific undertaking that took years and some US$3 billion to achieve.


March 8, 2016

For less than $1,000 you can now pull up your entire genome on your smartphone

By Sarah Buhr, TechCrunch

Veritas Genetics was one of the first companies to sequence the entire human genome for less than $1,000 in 2015. It’s now taken that technology a step further by delivering the results of your entire genome in an app.


March 6, 2016

With $999 Whole-Genome Sequencing Service, Veritas Embarks on Goal to Democratize DNA Information

By Turna Ray, GenomeWeb

LA JOLLA, Calif. – Veritas Genetics last week announced the availability of myGenome, a service that provides whole-genome sequencing, interpretation, and genetic counseling for $999 — a price point that experts in the field have long predicted would drive mainstream market adoption of the technology.


March 4, 2016

'Truth' for Less Than a Thousand

By GenomeWeb

Veritas Genetics says it can sequence and interpret your genome as well as provide genetic counseling for less than $1,000, Business Insider reports.
With its $999 myGenome test, Veritas Genetics, which was co-founded by Harvard Medical School's George Church, says in a press release that it will be making whole genome sequencing and interpretation widely available.


March 4, 2016

For $999, Veritas Genetics will put your genome on a smartphone app.

By Antonio Regalado, MIT Technology Review: Biomedicine

The $1,000 genome is a reality. Actually, you’ll save a dollar. It’s $999. A Cambridge, Massachusetts, company, Veritas Genetics, said this week that is how much it will charge for a consumer-friendly know-your-genome service that would pair insight into your genetic makeup with a handy phone app and on-demand video calls with genetic counselors.


February 22, 2016

DNA App Store: An online store for information about your genes will make it cheap and easy to learn more about your health risks and predispositions.

By Antonio Regalado, MIT Tech Review’s 10 Breakthrough Technologies

While driving and listening to National Public Radio one day, Justin Kao heard about the discovery of a “sweet tooth gene” that makes you more likely to crave sweets. “Oh my God,” thought Kao, who has always loved cookies. “I would pay $5 to know if I had that.”


January 16, 2016

Monitoring techniques for hereditary breast and ovarian cancer being developed

By Colin G. Evans, PhD, Targeted Oncology

A new 26-gene-screening panel, dubbed myBRCA HiRisk by its developer, Veritas Genetics, hitting the market in the first quarter of 2016 aims to advance the prevention of hereditary breast and ovarian cancer (HBOC).


October 27, 2015

Getting one test could save your life.

By Mickey, A Helicopter Mom blog

It is October – which means it is Breast Cancer Awareness month. Everywhere you look you will see pink ribbons, fundraisers, organized walks, etc. But how much do you REALLY know about breast cancer? And are you at risk? In the U.S., 1 in 8 women will be diagnosed with breast cancer at some time during her life.


October 2, 2015

Entire human genome can now be sequenced for just $1,000.

By Justine Alford, IFL Science

It took 13 years and close to $3 billion (£2 billion) to get to know our DNA from tip to tip. And it’s no wonder: our genomes contain more than 3 billion chemical building blocks, or bases, that all had to be read. But we have come a Veritas Genetics In The News (as of Feb 27, 2016) long way since then. So far, in fact, that individuals can now get their entire genome sequenced for less than $1,000 (£650). This is about much more than competitive pricing, though.


October 1, 2015

You'll soon be able to pay $1,000 to see your genetic map. Veritas Genetics cracks long-sought affordable genome sequencing.

By Peter Rugg, Inverse

The head of a Massachusetts genetics company says anyone with $1,000 will be able to chart their genetic makeup “sooner than you’d think.” “Ten years from now we’re going to look back and say ‘Why did we ever guess?’” Veritas Genetics CEO and co-founder Mirza Cifric tells Inverse. “


September 30, 2015

Your full genome can be sequenced and analyzed for just $1,000. It used to cost $100 million just a few years ago.

By Alexandra Ossola, Popular Science

Yesterday, personal genetics company Veritas Genetics announced that it had reached a milestone: participants in its limited, but steadily expanding Personal Genetics Program can get their entire genome sequenced for just $1,000.


September 29, 2015

Has Veritas Genetics broken the $1,000 genome barrier?

By Liz Harley, Front Line Genomics

Sequencing an entire genome for $1,000 is considered a crucial tipping point in genomics. Breaking that barrier could make sequencing commonplace, and bring genomic services within reach of the budgets of many healthcare providers. In 2014 Illumina announced the barrier broken by its HiSeq X Ten sequencer. However, this bold assessment has been criticised by some in the community for not including the cost of interpretation.


September 25, 2015

Low-cost genomic sequencing on the slate for China with Veritas landing?

By EJ Lane, Nova Medica

Boston-based Veritas Genetics has set up an R&D center in China's Hangzhou Economic & Technological Development Area aimed at genomic screening and testing product development for an Asian population.


August 25, 2015

Veritas Genetics get green light to offer hereditary cancer screening across Europe.

By Liz Harley, Front Line Genomics

Direct-to-consumer genetic testing is a divisive issue. Supporters of the technology often consider it empowering to be able to explore their own genomes, while detractors remain concerned that such tests can create false alarm or even false hope in consumers. Thus far Veritas Genetics, manufacturers of the myBRCA test that launched in May this year, have worked hard to establish their reliability and sound ethical credentials.


June 11, 2015

Veritas Genetics enters BRCA1/2 space with $199 test.

By GenomeWeb

NEW YORK (GenomeWeb) – Saying it wants to make genetic testing for cancer more widely available, startup Veritas Genetics recently launched its first test for BRCA1 and BRCA2 testing for $199, the first of what its CEO said will be several tests that the company will make available over the remainder of 2015 and beyond.


June 3, 2015

Danvers company wants to expand access to cheaper genetic tests.

By Jessica Bartlett, Boston Business Journal

Veritas Genetics is hoping to expand its breast and ovarian cancer genetic testing platform to other diseases and to other markets, thanks to $10 million in Series A funding.
The funding, which came from Lilly Asia Ventures, is only the latest for the Danvers-based company